
Christopher R. Stone
Examiner (ID: 10415, Phone: (571)270-3494 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1609, 1614, 1628, 4173 |
| Total Applications | 750 |
| Issued Applications | 250 |
| Pending Applications | 42 |
| Abandoned Applications | 457 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5721272
[patent_doc_number] => 20060074047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Method of treating inflammation with inhibitors of sialyl transferases'
[patent_app_type] => utility
[patent_app_number] => 11/244551
[patent_app_country] => US
[patent_app_date] => 2005-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6331
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074047.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244551
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244551 | Method of treating inflammation with inhibitors of sialyl transferases | Oct 5, 2005 | Abandoned |
Array
(
[id] => 5860261
[patent_doc_number] => 20060229470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Calcium receptor-active molecules'
[patent_app_type] => utility
[patent_app_number] => 11/242079
[patent_app_country] => US
[patent_app_date] => 2005-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 135
[patent_figures_cnt] => 135
[patent_no_of_words] => 56825
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20060229470.pdf
[firstpage_image] =>[orig_patent_app_number] => 11242079
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/242079 | Calcium receptor-active molecules | Oct 3, 2005 | Abandoned |
Array
(
[id] => 4734345
[patent_doc_number] => 20080051324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Medium-Chain Length Fatty Alcohols as Stimulators of Hematopoiesis'
[patent_app_type] => utility
[patent_app_number] => 11/663888
[patent_app_country] => US
[patent_app_date] => 2005-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5591
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20080051324.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663888
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663888 | Medium-chain length fatty alcohols as stimulators of hematopoiesis | Sep 28, 2005 | Issued |
Array
(
[id] => 4939453
[patent_doc_number] => 20080076772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Anti-Inflammatory Agents'
[patent_app_type] => utility
[patent_app_number] => 11/576115
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5769
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076772.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576115
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576115 | Anti-Inflammatory Agents | Sep 27, 2005 | Abandoned |
Array
(
[id] => 4758873
[patent_doc_number] => 20080311099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Pyridoxal-5-Phosphate and Related Compounds in Combination With Therapeutic Cardiovascular Compounds for Treating Angina'
[patent_app_type] => utility
[patent_app_number] => 11/663824
[patent_app_country] => US
[patent_app_date] => 2005-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12280
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311099.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663824
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663824 | Pyridoxal-5-Phosphate and Related Compounds in Combination With Therapeutic Cardiovascular Compounds for Treating Angina | Sep 25, 2005 | Abandoned |
Array
(
[id] => 5638162
[patent_doc_number] => 20060069136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Use of Epothilones in the treatment of bone metastasis'
[patent_app_type] => utility
[patent_app_number] => 11/233380
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6575
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069136.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233380
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233380 | Use of Epothilones in the treatment of bone metastasis | Sep 22, 2005 | Abandoned |
Array
(
[id] => 5807431
[patent_doc_number] => 20060093785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Apparatus, method and drug products for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures'
[patent_app_type] => utility
[patent_app_number] => 11/233487
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 21993
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093785.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233487
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233487 | Apparatus, method and drug products for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures | Sep 22, 2005 | Abandoned |
Array
(
[id] => 5829257
[patent_doc_number] => 20060063836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Method for treating renal disease'
[patent_app_type] => utility
[patent_app_number] => 11/229241
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4767
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063836.pdf
[firstpage_image] =>[orig_patent_app_number] => 11229241
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/229241 | Method for treating renal disease | Sep 15, 2005 | Abandoned |
Array
(
[id] => 5827095
[patent_doc_number] => 20060062822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Medical devices to treat or inhibit restenosis'
[patent_app_type] => utility
[patent_app_number] => 11/227729
[patent_app_country] => US
[patent_app_date] => 2005-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11908
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20060062822.pdf
[firstpage_image] =>[orig_patent_app_number] => 11227729
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/227729 | Medical devices to treat or inhibit restenosis | Sep 13, 2005 | Abandoned |
Array
(
[id] => 7535244
[patent_doc_number] => 08048870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-01
[patent_title] => 'Apoptosis-inducing antineoplastic silver (I) coordination complexes'
[patent_app_type] => utility
[patent_app_number] => 11/225565
[patent_app_country] => US
[patent_app_date] => 2005-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 24
[patent_no_of_words] => 13005
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/048/08048870.pdf
[firstpage_image] =>[orig_patent_app_number] => 11225565
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/225565 | Apoptosis-inducing antineoplastic silver (I) coordination complexes | Sep 12, 2005 | Issued |
Array
(
[id] => 5631013
[patent_doc_number] => 20060147482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Oral liquid pharmaceutical composition of leukotriene antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/223280
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3529
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147482.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223280
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223280 | Oral liquid pharmaceutical composition of leukotriene antagonists | Sep 8, 2005 | Abandoned |
Array
(
[id] => 5739091
[patent_doc_number] => 20060009482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Screening method for identifying compounds that selectively induce interferon alpha'
[patent_app_type] => utility
[patent_app_number] => 11/220235
[patent_app_country] => US
[patent_app_date] => 2005-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4457
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009482.pdf
[firstpage_image] =>[orig_patent_app_number] => 11220235
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/220235 | Screening method for identifying compounds that selectively induce interferon alpha | Sep 5, 2005 | Abandoned |
Array
(
[id] => 4746246
[patent_doc_number] => 20080090848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Substituted Purinyl Derivatives With Immunomodulator And Chemoprotective Activity And Use Alone Or With Medium-Chain Length Fatty Acids Or Glycerides'
[patent_app_type] => utility
[patent_app_number] => 11/661108
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5067
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090848.pdf
[firstpage_image] =>[orig_patent_app_number] => 11661108
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/661108 | Substituted Purinyl Derivatives With Immunomodulator And Chemoprotective Activity And Use Alone Or With Medium-Chain Length Fatty Acids Or Glycerides | Sep 1, 2005 | Abandoned |
Array
(
[id] => 8082081
[patent_doc_number] => 08148356
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Acetylcysteine composition and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/209804
[patent_app_country] => US
[patent_app_date] => 2005-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4315
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/148/08148356.pdf
[firstpage_image] =>[orig_patent_app_number] => 11209804
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/209804 | Acetylcysteine composition and uses therefor | Aug 23, 2005 | Issued |
Array
(
[id] => 4814038
[patent_doc_number] => 20080194669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'T Type Calcium Channel Blockers and the Treatment of Diseases'
[patent_app_type] => utility
[patent_app_number] => 11/660401
[patent_app_country] => US
[patent_app_date] => 2005-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7142
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194669.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660401
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660401 | T Type Calcium Channel Blockers and the Treatment of Diseases | Aug 21, 2005 | Abandoned |
Array
(
[id] => 5070181
[patent_doc_number] => 20070191283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues'
[patent_app_type] => utility
[patent_app_number] => 11/203639
[patent_app_country] => US
[patent_app_date] => 2005-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15975
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191283.pdf
[firstpage_image] =>[orig_patent_app_number] => 11203639
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/203639 | Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues | Aug 11, 2005 | Abandoned |
Array
(
[id] => 6978657
[patent_doc_number] => 20050288375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Method and composition for treating neurodegenerative disorders'
[patent_app_type] => utility
[patent_app_number] => 11/197942
[patent_app_country] => US
[patent_app_date] => 2005-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28840
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20050288375.pdf
[firstpage_image] =>[orig_patent_app_number] => 11197942
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/197942 | Method and composition for treating neurodegenerative disorders | Aug 4, 2005 | Abandoned |
Array
(
[id] => 4916364
[patent_doc_number] => 20080096965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => '(Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective Modulators'
[patent_app_type] => utility
[patent_app_number] => 11/574751
[patent_app_country] => US
[patent_app_date] => 2005-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8321
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096965.pdf
[firstpage_image] =>[orig_patent_app_number] => 11574751
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/574751 | (Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective Modulators | Jul 27, 2005 | Abandoned |
Array
(
[id] => 4652174
[patent_doc_number] => 20080039430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Pharmaceutical Compositions For The Treatment Of Leishmaniasis'
[patent_app_type] => utility
[patent_app_number] => 11/632845
[patent_app_country] => US
[patent_app_date] => 2005-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4006
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039430.pdf
[firstpage_image] =>[orig_patent_app_number] => 11632845
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/632845 | Pharmaceutical Compositions For The Treatment Of Leishmaniasis | Jul 14, 2005 | Abandoned |
Array
(
[id] => 4779533
[patent_doc_number] => 20080287531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Preventive and/or Therapeutic Agent for Sleeping Disorder'
[patent_app_type] => utility
[patent_app_number] => 11/570977
[patent_app_country] => US
[patent_app_date] => 2005-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4604
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287531.pdf
[firstpage_image] =>[orig_patent_app_number] => 11570977
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/570977 | Preventive and/or Therapeutic Agent for Sleeping Disorder | Jul 14, 2005 | Abandoned |